SignalCommodities
BASF (XTRA:BAS) Sets 2028 Debut For First Soybean Nematode Biotech Trait
BASF targets 2028 launch of first soybean nematode biotech trait.
Context
What happened: BASF (XTRA:BAS) plans to launch Nemasphere, described as the first biotech-based nematode resistance trait for soybeans, in 2028 for the US and Brazil markets, paired with Enlist E3 technology in its Seed Solutions portfolio.
Key numbers: Launch targeted for 2028. BASF described as a €46.2b chemicals group. Fair value cited at €52.47.
Why it matters: The trait feeds the view of Agricultural Solutions as a high margin growth driver, adding a differentiated product to a division analysts flag for strong EBITDA margins and IPO readiness, balancing more cyclical exposure.
What changed
BASF (XTRA:BAS) plans to launch Nemasphere, described as the first biotech-based nematode resistance trait for soybeans, in 2028 for the US and Brazil markets, paired with Enlist E3 technology in its Seed Solutions portfolio.
Why it matters
The trait feeds the view of Agricultural Solutions as a high margin growth driver, adding a differentiated product to a division analysts flag for strong EBITDA margins and IPO readiness, balancing more cyclical exposure.